Cytek Biosciences, Inc. (CTKB)
4.835
+0.04
(+0.73%)
USD |
NASDAQ |
Dec 19, 09:40
Cytek Biosciences Total Assets (Quarterly): 494.92M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Standard BioTools, Inc. | 539.64M |
| LENSAR, Inc. | 70.20M |
| Intelligent Bio Solutions, Inc. | 10.04M |
| Adagio Medical Holdings, Inc. | 31.55M |
| Movano, Inc. | 5.557M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 116.35M |
| Shareholders Equity (Quarterly) | 378.57M |
| Debt to Equity Ratio | 0.0929 |
| Current Ratio | 5.166 |
| Net Debt Paydown Yield | -0.09% |